Table 3.
Information on lung cancer samples in the test set.
Project name | Subproject | Number/percentage |
---|---|---|
Lung cancer | Adenocarcinoma | 89 (54.6%) |
Squamous carcinoma | 51 (31.3%) | |
Other cancers | 23 (14.1%) | |
Stage | Stage I | 67 (41.1%) |
Stage II | 96 (58.9%) | |
Gender | Male | 69 (42.3%) |
Female | 94 (57.7%) |